A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast Cancer

NCT04149444 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor withdrew support

Conditions

Metastatic Triple Negative Breast Cancer

Interventions

DRUG: Trifluridine/Tipiracil

Sponsor

AHS Cancer Control Alberta

Collaborators

[object Object]